Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial - Quiz - MDSpire

Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial

  • By

  • Bart L Clarke

  • Aliya A Khan

  • Mishaela R Rubin

  • Peter Schwarz

  • Tamara Vokes

  • Dolores M Shoback

  • Claudia Gagnon

  • Andrea Palermo

  • Lisa G Abbott

  • Lorenz C Hofbauer

  • Lynn Kohlmeier

  • Filomena Cetani

  • Susanne Pihl

  • Xuebei An

  • Alden R Smith

  • Bryant Lai

  • Jenny Ukena

  • Christopher T Sibley

  • Aimee D Shu

  • Lars Rejnmark

  • October 8, 2024

  • 0 min

Share

Original Source(s)

Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial

  • by Bart L Clarke, Aliya A Khan, Mishaela R Rubin, Peter Schwarz, Tamara Vokes, Dolores M Shoback, Claudia Gagnon, Andrea Palermo, Lisa G Abbott, Lorenz C Hofbauer, Lynn Kohlmeier, Filomena Cetani, Susanne Pihl, Xuebei An, Alden R Smith, Bryant Lai, Jenny Ukena, Christopher T Sibley, Aimee D Shu, Lars Rejnmark

  • October 8, 2024

Related Content

The Role of Muscular Fitness on Bone Mineral Content and Areal Bone Mineral Density in Youth With Type 1 Diabetes

Genetics and Bone Mineral Density Predict the Fractures in Adults With Osteogenesis Imperfecta: A Prospective Study

Phosphaturic mesenchymal tumor in the temporalis muscle causing tumor-induced osteomalacia: a case report and literature review